nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CYP2B6—Artemether—malaria	0.0412	0.0766	CbGbCtD
Nilotinib—CYP2C8—Sulfadiazine—malaria	0.0367	0.0683	CbGbCtD
Nilotinib—CYP2C8—Pyrimethamine—malaria	0.0367	0.0683	CbGbCtD
Nilotinib—CYP3A4—Clindamycin—malaria	0.0259	0.0482	CbGbCtD
Nilotinib—CYP2C9—Sulfadiazine—malaria	0.0256	0.0476	CbGbCtD
Nilotinib—CYP2C9—Pyrimethamine—malaria	0.0256	0.0476	CbGbCtD
Nilotinib—CYP2D6—Pyrimethamine—malaria	0.0234	0.0435	CbGbCtD
Nilotinib—CYP2B6—Quinidine—malaria	0.0219	0.0408	CbGbCtD
Nilotinib—CYP2C9—Artemether—malaria	0.0217	0.0405	CbGbCtD
Nilotinib—CYP2C9—Proguanil—malaria	0.0204	0.0381	CbGbCtD
Nilotinib—CYP2D6—Artemether—malaria	0.0199	0.037	CbGbCtD
Nilotinib—CYP2C8—Quinine—malaria	0.0189	0.0352	CbGbCtD
Nilotinib—CYP2D6—Proguanil—malaria	0.0187	0.0348	CbGbCtD
Nilotinib—CYP2D6—Quinidine barbiturate—malaria	0.0177	0.033	CbGbCtD
Nilotinib—CYP2C8—Quinidine—malaria	0.0166	0.0309	CbGbCtD
Nilotinib—CYP3A4—Sulfadiazine—malaria	0.0149	0.0277	CbGbCtD
Nilotinib—CYP2C8—Dapsone—malaria	0.0143	0.0266	CbGbCtD
Nilotinib—CYP2C9—Quinine—malaria	0.0132	0.0245	CbGbCtD
Nilotinib—ABCB1—Quinine—malaria	0.0128	0.0238	CbGbCtD
Nilotinib—CYP3A4—Artemether—malaria	0.0126	0.0235	CbGbCtD
Nilotinib—CYP2D6—Quinine—malaria	0.012	0.0224	CbGbCtD
Nilotinib—CYP3A4—Proguanil—malaria	0.0119	0.0221	CbGbCtD
Nilotinib—CYP2C9—Quinidine—malaria	0.0116	0.0216	CbGbCtD
Nilotinib—CYP3A4—Doxycycline—malaria	0.0113	0.021	CbGbCtD
Nilotinib—ABCB1—Quinidine—malaria	0.0112	0.0209	CbGbCtD
Nilotinib—CYP2D6—Quinidine—malaria	0.0106	0.0197	CbGbCtD
Nilotinib—CYP2C9—Dapsone—malaria	0.00999	0.0186	CbGbCtD
Nilotinib—CYP3A4—Quinine—malaria	0.00766	0.0143	CbGbCtD
Nilotinib—CYP3A4—Quinidine—malaria	0.00673	0.0125	CbGbCtD
Nilotinib—CYP3A4—Dapsone—malaria	0.00581	0.0108	CbGbCtD
Nilotinib—CA6—saliva—malaria	0.00444	0.0323	CbGeAlD
Nilotinib—Ponatinib—KDR—malaria	0.00404	1	CrCbGaD
Nilotinib—MAPK8—endothelium—malaria	0.00303	0.022	CbGeAlD
Nilotinib—TIE1—endothelium—malaria	0.00263	0.0191	CbGeAlD
Nilotinib—LYN—blood plasma—malaria	0.00248	0.0181	CbGeAlD
Nilotinib—FRK—hematopoietic system—malaria	0.00195	0.0142	CbGeAlD
Nilotinib—BLK—hematopoietic system—malaria	0.00188	0.0137	CbGeAlD
Nilotinib—EPHB2—hematopoietic system—malaria	0.00186	0.0135	CbGeAlD
Nilotinib—EPHB4—endothelium—malaria	0.00182	0.0133	CbGeAlD
Nilotinib—TEK—endothelium—malaria	0.00174	0.0127	CbGeAlD
Nilotinib—MAPK14—blood plasma—malaria	0.00171	0.0124	CbGeAlD
Nilotinib—MAPK8—hematopoietic system—malaria	0.00149	0.0108	CbGeAlD
Nilotinib—LYN—hematopoietic system—malaria	0.00137	0.00998	CbGeAlD
Nilotinib—MAP4K1—hematopoietic system—malaria	0.00135	0.00983	CbGeAlD
Nilotinib—UGT1A1—blood plasma—malaria	0.00134	0.00974	CbGeAlD
Nilotinib—EPHB2—digestive system—malaria	0.00129	0.00941	CbGeAlD
Nilotinib—TIE1—hematopoietic system—malaria	0.00129	0.00938	CbGeAlD
Nilotinib—EPHB3—saliva-secreting gland—malaria	0.00129	0.00935	CbGeAlD
Nilotinib—KIT—endothelium—malaria	0.00126	0.00919	CbGeAlD
Nilotinib—BLK—blood—malaria	0.00125	0.00907	CbGeAlD
Nilotinib—CSF1R—blood plasma—malaria	0.00124	0.00899	CbGeAlD
Nilotinib—MAPK8—kidney—malaria	0.00122	0.00887	CbGeAlD
Nilotinib—CDC42BPB—digestive system—malaria	0.00114	0.00832	CbGeAlD
Nilotinib—HCK—hematopoietic system—malaria	0.00113	0.0082	CbGeAlD
Nilotinib—KIT—blood plasma—malaria	0.00112	0.00816	CbGeAlD
Nilotinib—CA6—saliva-secreting gland—malaria	0.00112	0.00814	CbGeAlD
Nilotinib—MAPK8—digestive system—malaria	0.00103	0.00752	CbGeAlD
Nilotinib—CA1—blood plasma—malaria	0.00103	0.00747	CbGeAlD
Nilotinib—FRK—liver—malaria	0.00101	0.00735	CbGeAlD
Nilotinib—MAPK8—blood—malaria	0.000985	0.00717	CbGeAlD
Nilotinib—MAPK8—bone marrow—malaria	0.000953	0.00693	CbGeAlD
Nilotinib—MAPK14—hematopoietic system—malaria	0.000944	0.00687	CbGeAlD
Nilotinib—FGR—hematopoietic system—malaria	0.000941	0.00684	CbGeAlD
Nilotinib—EPHB4—saliva-secreting gland—malaria	0.000938	0.00682	CbGeAlD
Nilotinib—EPHA2—saliva-secreting gland—malaria	0.00092	0.00669	CbGeAlD
Nilotinib—LYN—blood—malaria	0.000909	0.00661	CbGeAlD
Nilotinib—CA7—kidney—malaria	0.000904	0.00658	CbGeAlD
Nilotinib—MAP4K1—blood—malaria	0.000895	0.00651	CbGeAlD
Nilotinib—EPHB4—hematopoietic system—malaria	0.000895	0.00651	CbGeAlD
Nilotinib—EPHA2—hematopoietic system—malaria	0.000878	0.00639	CbGeAlD
Nilotinib—MAP4K1—bone marrow—malaria	0.000866	0.0063	CbGeAlD
Nilotinib—EPHB6—saliva-secreting gland—malaria	0.000858	0.00624	CbGeAlD
Nilotinib—TEK—hematopoietic system—malaria	0.000857	0.00623	CbGeAlD
Nilotinib—EPHB3—digestive system—malaria	0.000853	0.0062	CbGeAlD
Nilotinib—CDC42BPB—liver—malaria	0.000852	0.0062	CbGeAlD
Nilotinib—BRAF—blood—malaria	0.000819	0.00596	CbGeAlD
Nilotinib—BRAF—bone marrow—malaria	0.000792	0.00576	CbGeAlD
Nilotinib—HCK—digestive system—malaria	0.000784	0.0057	CbGeAlD
Nilotinib—PDGFRA—hematopoietic system—malaria	0.000776	0.00565	CbGeAlD
Nilotinib—MAPK14—kidney—malaria	0.000774	0.00563	CbGeAlD
Nilotinib—MAPK8—liver—malaria	0.00077	0.0056	CbGeAlD
Nilotinib—CA7—digestive system—malaria	0.000767	0.00558	CbGeAlD
Nilotinib—EPHB2—brain—malaria	0.000765	0.00556	CbGeAlD
Nilotinib—HCK—blood—malaria	0.000747	0.00543	CbGeAlD
Nilotinib—ABL2—blood—malaria	0.000742	0.0054	CbGeAlD
Nilotinib—UGT1A1—hematopoietic system—malaria	0.000741	0.00539	CbGeAlD
Nilotinib—EPHB4—kidney—malaria	0.000734	0.00534	CbGeAlD
Nilotinib—MAP2K5—saliva-secreting gland—malaria	0.000734	0.00534	CbGeAlD
Nilotinib—EPHA8—brain—malaria	0.000733	0.00533	CbGeAlD
Nilotinib—HCK—bone marrow—malaria	0.000723	0.00526	CbGeAlD
Nilotinib—LYN—liver—malaria	0.000711	0.00517	CbGeAlD
Nilotinib—TEK—kidney—malaria	0.000702	0.00511	CbGeAlD
Nilotinib—CSF1R—hematopoietic system—malaria	0.000683	0.00497	CbGeAlD
Nilotinib—MAPK11—brain—malaria	0.000682	0.00496	CbGeAlD
Nilotinib—EPHA4—blood—malaria	0.000679	0.00494	CbGeAlD
Nilotinib—CDC42BPB—brain—malaria	0.000676	0.00492	CbGeAlD
Nilotinib—CA9—digestive system—malaria	0.000674	0.0049	CbGeAlD
Nilotinib—TIE1—liver—malaria	0.000668	0.00486	CbGeAlD
Nilotinib—CA2—blood plasma—malaria	0.000665	0.00484	CbGeAlD
Nilotinib—MAPK14—digestive system—malaria	0.000657	0.00478	CbGeAlD
Nilotinib—FGR—digestive system—malaria	0.000654	0.00476	CbGeAlD
Nilotinib—KIT—saliva-secreting gland—malaria	0.00065	0.00473	CbGeAlD
Nilotinib—CA3—bone marrow—malaria	0.000649	0.00472	CbGeAlD
Nilotinib—EPHA3—brain—malaria	0.000641	0.00466	CbGeAlD
Nilotinib—BRAF—liver—malaria	0.00064	0.00466	CbGeAlD
Nilotinib—PDGFRB—saliva-secreting gland—malaria	0.000635	0.00462	CbGeAlD
Nilotinib—CYP2C8—blood plasma—malaria	0.000634	0.00461	CbGeAlD
Nilotinib—MAPK14—blood—malaria	0.000626	0.00455	CbGeAlD
Nilotinib—FGR—blood—malaria	0.000623	0.00453	CbGeAlD
Nilotinib—LCK—blood—malaria	0.000623	0.00453	CbGeAlD
Nilotinib—EPHB4—digestive system—malaria	0.000623	0.00453	CbGeAlD
Nilotinib—KIT—hematopoietic system—malaria	0.000621	0.00451	CbGeAlD
Nilotinib—MAPK8—brain—malaria	0.000611	0.00445	CbGeAlD
Nilotinib—EPHA6—brain—malaria	0.000611	0.00445	CbGeAlD
Nilotinib—EPHA2—digestive system—malaria	0.000611	0.00444	CbGeAlD
Nilotinib—UGT1A1—kidney—malaria	0.000607	0.00442	CbGeAlD
Nilotinib—PDGFRB—hematopoietic system—malaria	0.000606	0.00441	CbGeAlD
Nilotinib—MAPK14—bone marrow—malaria	0.000605	0.0044	CbGeAlD
Nilotinib—FGR—bone marrow—malaria	0.000603	0.00439	CbGeAlD
Nilotinib—LCK—bone marrow—malaria	0.000603	0.00439	CbGeAlD
Nilotinib—EPHB4—blood—malaria	0.000593	0.00431	CbGeAlD
Nilotinib—CA12—kidney—malaria	0.000587	0.00427	CbGeAlD
Nilotinib—HCK—liver—malaria	0.000584	0.00425	CbGeAlD
Nilotinib—EPHA2—blood—malaria	0.000582	0.00423	CbGeAlD
Nilotinib—ABL2—liver—malaria	0.00058	0.00422	CbGeAlD
Nilotinib—EPHB4—bone marrow—malaria	0.000574	0.00418	CbGeAlD
Nilotinib—CYP2B6—blood plasma—malaria	0.000568	0.00413	CbGeAlD
Nilotinib—TEK—blood—malaria	0.000568	0.00413	CbGeAlD
Nilotinib—CA1—hematopoietic system—malaria	0.000568	0.00413	CbGeAlD
Nilotinib—ABL1—saliva-secreting gland—malaria	0.000566	0.00412	CbGeAlD
Nilotinib—LYN—brain—malaria	0.000564	0.0041	CbGeAlD
Nilotinib—CYP2C9—blood plasma—malaria	0.000563	0.00409	CbGeAlD
Nilotinib—MAP4K1—brain—malaria	0.000556	0.00404	CbGeAlD
Nilotinib—EPHB6—blood—malaria	0.000543	0.00395	CbGeAlD
Nilotinib—ABL1—hematopoietic system—malaria	0.00054	0.00393	CbGeAlD
Nilotinib—PDGFRA—digestive system—malaria	0.00054	0.00393	CbGeAlD
Nilotinib—TIE1—brain—malaria	0.00053	0.00386	CbGeAlD
Nilotinib—CA3—liver—malaria	0.000524	0.00381	CbGeAlD
Nilotinib—UGT1A1—digestive system—malaria	0.000515	0.00375	CbGeAlD
Nilotinib—PDGFRA—blood—malaria	0.000514	0.00374	CbGeAlD
Nilotinib—KIT—kidney—malaria	0.000509	0.0037	CbGeAlD
Nilotinib—BRAF—brain—malaria	0.000508	0.0037	CbGeAlD
Nilotinib—EPHB3—brain—malaria	0.000504	0.00367	CbGeAlD
Nilotinib—CA12—digestive system—malaria	0.000498	0.00362	CbGeAlD
Nilotinib—PDGFRB—kidney—malaria	0.000497	0.00361	CbGeAlD
Nilotinib—UGT1A1—blood—malaria	0.000491	0.00357	CbGeAlD
Nilotinib—MAPK14—liver—malaria	0.000489	0.00356	CbGeAlD
Nilotinib—FGR—liver—malaria	0.000487	0.00354	CbGeAlD
Nilotinib—LCK—liver—malaria	0.000487	0.00354	CbGeAlD
Nilotinib—CA14—liver—malaria	0.000476	0.00346	CbGeAlD
Nilotinib—CSF1R—digestive system—malaria	0.000475	0.00346	CbGeAlD
Nilotinib—CA1—kidney—malaria	0.000465	0.00338	CbGeAlD
Nilotinib—CA4—saliva-secreting gland—malaria	0.000465	0.00338	CbGeAlD
Nilotinib—MAP2K5—blood—malaria	0.000464	0.00337	CbGeAlD
Nilotinib—EPHB4—liver—malaria	0.000464	0.00337	CbGeAlD
Nilotinib—HCK—brain—malaria	0.000463	0.00337	CbGeAlD
Nilotinib—ABL2—brain—malaria	0.00046	0.00335	CbGeAlD
Nilotinib—EPHA2—liver—malaria	0.000455	0.00331	CbGeAlD
Nilotinib—CA7—brain—malaria	0.000453	0.0033	CbGeAlD
Nilotinib—CSF1R—blood—malaria	0.000453	0.00329	CbGeAlD
Nilotinib—TEK—liver—malaria	0.000444	0.00323	CbGeAlD
Nilotinib—ABL1—kidney—malaria	0.000443	0.00322	CbGeAlD
Nilotinib—CSF1R—bone marrow—malaria	0.000438	0.00319	CbGeAlD
Nilotinib—KIT—digestive system—malaria	0.000432	0.00314	CbGeAlD
Nilotinib—CYP3A4—blood plasma—malaria	0.000429	0.00312	CbGeAlD
Nilotinib—CYP2D6—blood plasma—malaria	0.000422	0.00307	CbGeAlD
Nilotinib—PDGFRB—digestive system—malaria	0.000422	0.00307	CbGeAlD
Nilotinib—EPHA4—brain—malaria	0.000421	0.00306	CbGeAlD
Nilotinib—CA3—brain—malaria	0.000416	0.00303	CbGeAlD
Nilotinib—KIT—blood—malaria	0.000411	0.00299	CbGeAlD
Nilotinib—PDGFRA—liver—malaria	0.000402	0.00293	CbGeAlD
Nilotinib—PDGFRB—blood—malaria	0.000402	0.00292	CbGeAlD
Nilotinib—KIT—bone marrow—malaria	0.000398	0.00289	CbGeAlD
Nilotinib—CA1—digestive system—malaria	0.000395	0.00287	CbGeAlD
Nilotinib—PDGFRB—bone marrow—malaria	0.000389	0.00283	CbGeAlD
Nilotinib—MAPK14—brain—malaria	0.000388	0.00282	CbGeAlD
Nilotinib—FGR—brain—malaria	0.000387	0.00281	CbGeAlD
Nilotinib—CA2—saliva-secreting gland—malaria	0.000385	0.0028	CbGeAlD
Nilotinib—UGT1A1—liver—malaria	0.000384	0.00279	CbGeAlD
Nilotinib—CA14—brain—malaria	0.000378	0.00275	CbGeAlD
Nilotinib—CA1—blood—malaria	0.000376	0.00274	CbGeAlD
Nilotinib—ABL1—digestive system—malaria	0.000376	0.00273	CbGeAlD
Nilotinib—EPHB4—brain—malaria	0.000368	0.00268	CbGeAlD
Nilotinib—CA2—hematopoietic system—malaria	0.000368	0.00268	CbGeAlD
Nilotinib—CA1—bone marrow—malaria	0.000364	0.00265	CbGeAlD
Nilotinib—CA4—kidney—malaria	0.000364	0.00265	CbGeAlD
Nilotinib—MAP2K5—liver—malaria	0.000363	0.00264	CbGeAlD
Nilotinib—EPHA2—brain—malaria	0.000361	0.00263	CbGeAlD
Nilotinib—ABL1—blood—malaria	0.000358	0.0026	CbGeAlD
Nilotinib—ABCG2—saliva-secreting gland—malaria	0.000357	0.0026	CbGeAlD
Nilotinib—CSF1R—liver—malaria	0.000354	0.00258	CbGeAlD
Nilotinib—TEK—brain—malaria	0.000352	0.00256	CbGeAlD
Nilotinib—CYP2C8—hematopoietic system—malaria	0.00035	0.00255	CbGeAlD
Nilotinib—ABL1—bone marrow—malaria	0.000346	0.00252	CbGeAlD
Nilotinib—EPHB6—brain—malaria	0.000337	0.00245	CbGeAlD
Nilotinib—KIT—liver—malaria	0.000322	0.00234	CbGeAlD
Nilotinib—PDGFRA—brain—malaria	0.000319	0.00232	CbGeAlD
Nilotinib—CYP2B6—hematopoietic system—malaria	0.000314	0.00229	CbGeAlD
Nilotinib—PDGFRB—liver—malaria	0.000314	0.00228	CbGeAlD
Nilotinib—CYP2C9—hematopoietic system—malaria	0.000311	0.00226	CbGeAlD
Nilotinib—CA4—digestive system—malaria	0.000309	0.00224	CbGeAlD
Nilotinib—ABCB1—blood plasma—malaria	0.000304	0.00221	CbGeAlD
Nilotinib—CA2—kidney—malaria	0.000302	0.00219	CbGeAlD
Nilotinib—CA12—brain—malaria	0.000295	0.00214	CbGeAlD
Nilotinib—CA1—liver—malaria	0.000294	0.00214	CbGeAlD
Nilotinib—CA4—blood—malaria	0.000294	0.00214	CbGeAlD
Nilotinib—Insomnia—Sulfadiazine—malaria	0.000288	0.00164	CcSEcCtD
Nilotinib—MAP2K5—brain—malaria	0.000288	0.00209	CbGeAlD
Nilotinib—CYP2C8—kidney—malaria	0.000287	0.00209	CbGeAlD
Nilotinib—Mental disorder—Quinidine—malaria	0.000287	0.00163	CcSEcCtD
Nilotinib—Mental disorder—Quinine—malaria	0.000287	0.00163	CcSEcCtD
Nilotinib—Flatulence—Clindamycin—malaria	0.000286	0.00163	CcSEcCtD
Nilotinib—Malnutrition—Quinidine—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Erythema—Quinidine—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Malnutrition—Quinine—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Erythema—Quinine—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Nausea—Proguanil—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Visual impairment—Quinidine barbiturate—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—Dysgeusia—Clindamycin—malaria	0.000285	0.00162	CcSEcCtD
Nilotinib—CA4—bone marrow—malaria	0.000284	0.00207	CbGeAlD
Nilotinib—Vision blurred—Dapsone—malaria	0.000283	0.00161	CcSEcCtD
Nilotinib—Back pain—Clindamycin—malaria	0.000281	0.0016	CcSEcCtD
Nilotinib—CSF1R—brain—malaria	0.000281	0.00204	CbGeAlD
Nilotinib—ABL1—liver—malaria	0.00028	0.00204	CbGeAlD
Nilotinib—Erythema multiforme—Quinidine barbiturate—malaria	0.000279	0.00159	CcSEcCtD
Nilotinib—Muscle spasms—Clindamycin—malaria	0.000279	0.00159	CcSEcCtD
Nilotinib—Decreased appetite—Sulfadiazine—malaria	0.000277	0.00157	CcSEcCtD
Nilotinib—Eye disorder—Quinidine barbiturate—malaria	0.000276	0.00157	CcSEcCtD
Nilotinib—Tinnitus—Quinidine barbiturate—malaria	0.000276	0.00157	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000275	0.00156	CcSEcCtD
Nilotinib—Flushing—Quinidine barbiturate—malaria	0.000274	0.00156	CcSEcCtD
Nilotinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000274	0.00156	CcSEcCtD
Nilotinib—Flushing—Pentoxifylline—malaria	0.000274	0.00156	CcSEcCtD
Nilotinib—Vertigo—Dapsone—malaria	0.00027	0.00153	CcSEcCtD
Nilotinib—Vision blurred—Quinidine—malaria	0.000269	0.00153	CcSEcCtD
Nilotinib—Vision blurred—Quinine—malaria	0.000269	0.00153	CcSEcCtD
Nilotinib—Anaemia—Clindamycin—malaria	0.000269	0.00153	CcSEcCtD
Nilotinib—Tremor—Quinidine—malaria	0.000267	0.00152	CcSEcCtD
Nilotinib—Tremor—Quinine—malaria	0.000267	0.00152	CcSEcCtD
Nilotinib—Immune system disorder—Quinidine barbiturate—malaria	0.000267	0.00152	CcSEcCtD
Nilotinib—Immune system disorder—Pentoxifylline—malaria	0.000266	0.00151	CcSEcCtD
Nilotinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000266	0.00151	CcSEcCtD
Nilotinib—Chills—Quinidine barbiturate—malaria	0.000265	0.00151	CcSEcCtD
Nilotinib—Arrhythmia—Pentoxifylline—malaria	0.000263	0.0015	CcSEcCtD
Nilotinib—Cough—Dapsone—malaria	0.000262	0.00149	CcSEcCtD
Nilotinib—Vertigo—Clindamycin—malaria	0.000261	0.00148	CcSEcCtD
Nilotinib—Gastrointestinal pain—Sulfadiazine—malaria	0.00026	0.00148	CcSEcCtD
Nilotinib—Leukopenia—Clindamycin—malaria	0.00026	0.00148	CcSEcCtD
Nilotinib—Mental disorder—Quinidine barbiturate—malaria	0.000259	0.00147	CcSEcCtD
Nilotinib—CYP2B6—kidney—malaria	0.000258	0.00187	CbGeAlD
Nilotinib—Erythema—Quinidine barbiturate—malaria	0.000257	0.00146	CcSEcCtD
Nilotinib—Malnutrition—Quinidine barbiturate—malaria	0.000257	0.00146	CcSEcCtD
Nilotinib—Erythema—Pentoxifylline—malaria	0.000257	0.00146	CcSEcCtD
Nilotinib—Vertigo—Quinidine—malaria	0.000256	0.00145	CcSEcCtD
Nilotinib—Vertigo—Quinine—malaria	0.000256	0.00145	CcSEcCtD
Nilotinib—CA2—digestive system—malaria	0.000256	0.00186	CbGeAlD
Nilotinib—Syncope—Quinidine—malaria	0.000256	0.00145	CcSEcCtD
Nilotinib—Syncope—Quinine—malaria	0.000256	0.00145	CcSEcCtD
Nilotinib—Leukopenia—Quinine—malaria	0.000255	0.00145	CcSEcCtD
Nilotinib—Leukopenia—Quinidine—malaria	0.000255	0.00145	CcSEcCtD
Nilotinib—KIT—brain—malaria	0.000255	0.00186	CbGeAlD
Nilotinib—Flatulence—Pentoxifylline—malaria	0.000253	0.00144	CcSEcCtD
Nilotinib—Urticaria—Sulfadiazine—malaria	0.000253	0.00144	CcSEcCtD
Nilotinib—Palpitations—Quinine—malaria	0.000252	0.00143	CcSEcCtD
Nilotinib—Palpitations—Quinidine—malaria	0.000252	0.00143	CcSEcCtD
Nilotinib—Body temperature increased—Sulfadiazine—malaria	0.000252	0.00143	CcSEcCtD
Nilotinib—Abdominal pain—Sulfadiazine—malaria	0.000252	0.00143	CcSEcCtD
Nilotinib—Dysgeusia—Pentoxifylline—malaria	0.000251	0.00143	CcSEcCtD
Nilotinib—Hypertension—Clindamycin—malaria	0.000251	0.00143	CcSEcCtD
Nilotinib—Loss of consciousness—Quinine—malaria	0.000251	0.00142	CcSEcCtD
Nilotinib—Loss of consciousness—Quinidine—malaria	0.000251	0.00142	CcSEcCtD
Nilotinib—PDGFRB—brain—malaria	0.000249	0.00181	CbGeAlD
Nilotinib—Back pain—Pentoxifylline—malaria	0.000248	0.00141	CcSEcCtD
Nilotinib—Muscle spasms—Pentoxifylline—malaria	0.000247	0.0014	CcSEcCtD
Nilotinib—Discomfort—Clindamycin—malaria	0.000244	0.00139	CcSEcCtD
Nilotinib—CA2—blood—malaria	0.000244	0.00177	CbGeAlD
Nilotinib—Myalgia—Quinine—malaria	0.000243	0.00138	CcSEcCtD
Nilotinib—Myalgia—Quinidine—malaria	0.000243	0.00138	CcSEcCtD
Nilotinib—Chest pain—Quinine—malaria	0.000243	0.00138	CcSEcCtD
Nilotinib—Chest pain—Quinidine—malaria	0.000243	0.00138	CcSEcCtD
Nilotinib—Vision blurred—Quinidine barbiturate—malaria	0.000242	0.00138	CcSEcCtD
Nilotinib—Vision blurred—Pentoxifylline—malaria	0.000242	0.00137	CcSEcCtD
Nilotinib—Tremor—Quinidine barbiturate—malaria	0.000241	0.00137	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000241	0.00137	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000241	0.00137	CcSEcCtD
Nilotinib—Tremor—Pentoxifylline—malaria	0.000241	0.00137	CcSEcCtD
Nilotinib—Tachycardia—Dapsone—malaria	0.000239	0.00136	CcSEcCtD
Nilotinib—Ill-defined disorder—Pentoxifylline—malaria	0.000238	0.00135	CcSEcCtD
Nilotinib—CYP3A4—hematopoietic system—malaria	0.000237	0.00173	CbGeAlD
Nilotinib—Anaemia—Pentoxifylline—malaria	0.000237	0.00135	CcSEcCtD
Nilotinib—CA2—bone marrow—malaria	0.000236	0.00172	CbGeAlD
Nilotinib—Hypersensitivity—Sulfadiazine—malaria	0.000235	0.00133	CcSEcCtD
Nilotinib—Confusional state—Quinine—malaria	0.000235	0.00133	CcSEcCtD
Nilotinib—Confusional state—Quinidine—malaria	0.000235	0.00133	CcSEcCtD
Nilotinib—CYP2D6—hematopoietic system—malaria	0.000234	0.0017	CbGeAlD
Nilotinib—CA1—brain—malaria	0.000233	0.0017	CbGeAlD
Nilotinib—Oedema—Quinidine—malaria	0.000233	0.00132	CcSEcCtD
Nilotinib—Oedema—Quinine—malaria	0.000233	0.00132	CcSEcCtD
Nilotinib—Thrombocytopenia—Clindamycin—malaria	0.000232	0.00132	CcSEcCtD
Nilotinib—CYP2C8—blood—malaria	0.000232	0.00169	CbGeAlD
Nilotinib—Malaise—Pentoxifylline—malaria	0.000232	0.00132	CcSEcCtD
Nilotinib—Vertigo—Quinidine barbiturate—malaria	0.000231	0.00131	CcSEcCtD
Nilotinib—Syncope—Quinidine barbiturate—malaria	0.000231	0.00131	CcSEcCtD
Nilotinib—Leukopenia—Quinidine barbiturate—malaria	0.00023	0.00131	CcSEcCtD
Nilotinib—Leukopenia—Pentoxifylline—malaria	0.00023	0.00131	CcSEcCtD
Nilotinib—Shock—Quinine—malaria	0.000229	0.0013	CcSEcCtD
Nilotinib—Shock—Quinidine—malaria	0.000229	0.0013	CcSEcCtD
Nilotinib—Nervous system disorder—Quinidine—malaria	0.000228	0.0013	CcSEcCtD
Nilotinib—Nervous system disorder—Quinine—malaria	0.000228	0.0013	CcSEcCtD
Nilotinib—Thrombocytopenia—Quinidine—malaria	0.000228	0.00129	CcSEcCtD
Nilotinib—Thrombocytopenia—Quinine—malaria	0.000228	0.00129	CcSEcCtD
Nilotinib—Palpitations—Quinidine barbiturate—malaria	0.000227	0.00129	CcSEcCtD
Nilotinib—Tachycardia—Quinidine—malaria	0.000227	0.00129	CcSEcCtD
Nilotinib—Tachycardia—Quinine—malaria	0.000227	0.00129	CcSEcCtD
Nilotinib—Palpitations—Pentoxifylline—malaria	0.000227	0.00129	CcSEcCtD
Nilotinib—Loss of consciousness—Quinidine barbiturate—malaria	0.000226	0.00128	CcSEcCtD
Nilotinib—Skin disorder—Quinidine—malaria	0.000226	0.00128	CcSEcCtD
Nilotinib—Skin disorder—Quinine—malaria	0.000226	0.00128	CcSEcCtD
Nilotinib—ABCG2—blood—malaria	0.000226	0.00164	CbGeAlD
Nilotinib—Pruritus—Sulfadiazine—malaria	0.000225	0.00128	CcSEcCtD
Nilotinib—Hyperhidrosis—Quinine—malaria	0.000225	0.00128	CcSEcCtD
Nilotinib—Hyperhidrosis—Quinidine—malaria	0.000225	0.00128	CcSEcCtD
Nilotinib—ABL1—brain—malaria	0.000222	0.00162	CbGeAlD
Nilotinib—Anorexia—Quinine—malaria	0.000222	0.00126	CcSEcCtD
Nilotinib—Anorexia—Quinidine—malaria	0.000222	0.00126	CcSEcCtD
Nilotinib—Insomnia—Dapsone—malaria	0.000222	0.00126	CcSEcCtD
Nilotinib—Hypertension—Pentoxifylline—malaria	0.000222	0.00126	CcSEcCtD
Nilotinib—Hypotension—Clindamycin—malaria	0.000222	0.00126	CcSEcCtD
Nilotinib—Arthralgia—Quinidine barbiturate—malaria	0.000219	0.00124	CcSEcCtD
Nilotinib—Myalgia—Quinidine barbiturate—malaria	0.000219	0.00124	CcSEcCtD
Nilotinib—Chest pain—Quinidine barbiturate—malaria	0.000219	0.00124	CcSEcCtD
Nilotinib—Myalgia—Pentoxifylline—malaria	0.000219	0.00124	CcSEcCtD
Nilotinib—Chest pain—Pentoxifylline—malaria	0.000219	0.00124	CcSEcCtD
Nilotinib—CYP2B6—digestive system—malaria	0.000219	0.00159	CbGeAlD
Nilotinib—ABCG2—bone marrow—malaria	0.000218	0.00159	CbGeAlD
Nilotinib—Anxiety—Quinidine barbiturate—malaria	0.000218	0.00124	CcSEcCtD
Nilotinib—Diarrhoea—Sulfadiazine—malaria	0.000218	0.00124	CcSEcCtD
Nilotinib—Anxiety—Pentoxifylline—malaria	0.000218	0.00124	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000217	0.00124	CcSEcCtD
Nilotinib—Hypotension—Quinine—malaria	0.000217	0.00123	CcSEcCtD
Nilotinib—Hypotension—Quinidine—malaria	0.000217	0.00123	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000217	0.00123	CcSEcCtD
Nilotinib—CYP2C9—digestive system—malaria	0.000216	0.00157	CbGeAlD
Nilotinib—Discomfort—Pentoxifylline—malaria	0.000216	0.00123	CcSEcCtD
Nilotinib—Dry mouth—Pentoxifylline—malaria	0.000214	0.00121	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Quinidine—malaria	0.000212	0.0012	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Quinine—malaria	0.000212	0.0012	CcSEcCtD
Nilotinib—Confusional state—Quinidine barbiturate—malaria	0.000212	0.0012	CcSEcCtD
Nilotinib—Dyspnoea—Clindamycin—malaria	0.000211	0.0012	CcSEcCtD
Nilotinib—Confusional state—Pentoxifylline—malaria	0.000211	0.0012	CcSEcCtD
Nilotinib—Oedema—Quinidine barbiturate—malaria	0.00021	0.00119	CcSEcCtD
Nilotinib—Oedema—Pentoxifylline—malaria	0.00021	0.00119	CcSEcCtD
Nilotinib—Dyspepsia—Clindamycin—malaria	0.000209	0.00119	CcSEcCtD
Nilotinib—CYP2B6—blood—malaria	0.000208	0.00151	CbGeAlD
Nilotinib—Infection—Pentoxifylline—malaria	0.000208	0.00118	CcSEcCtD
Nilotinib—Dyspnoea—Quinidine—malaria	0.000207	0.00118	CcSEcCtD
Nilotinib—Dyspnoea—Quinine—malaria	0.000207	0.00118	CcSEcCtD
Nilotinib—Shock—Quinidine barbiturate—malaria	0.000207	0.00117	CcSEcCtD
Nilotinib—CYP2C9—blood—malaria	0.000206	0.0015	CbGeAlD
Nilotinib—Shock—Pentoxifylline—malaria	0.000206	0.00117	CcSEcCtD
Nilotinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000206	0.00117	CcSEcCtD
Nilotinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000206	0.00117	CcSEcCtD
Nilotinib—Thrombocytopenia—Pentoxifylline—malaria	0.000205	0.00117	CcSEcCtD
Nilotinib—Tachycardia—Quinidine barbiturate—malaria	0.000205	0.00116	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Clindamycin—malaria	0.000205	0.00116	CcSEcCtD
Nilotinib—Tachycardia—Pentoxifylline—malaria	0.000205	0.00116	CcSEcCtD
Nilotinib—Fatigue—Clindamycin—malaria	0.000204	0.00116	CcSEcCtD
Nilotinib—Skin disorder—Quinidine barbiturate—malaria	0.000204	0.00116	CcSEcCtD
Nilotinib—Skin disorder—Pentoxifylline—malaria	0.000204	0.00116	CcSEcCtD
Nilotinib—Hyperhidrosis—Quinidine barbiturate—malaria	0.000203	0.00115	CcSEcCtD
Nilotinib—Pain—Clindamycin—malaria	0.000203	0.00115	CcSEcCtD
Nilotinib—Constipation—Clindamycin—malaria	0.000203	0.00115	CcSEcCtD
Nilotinib—Hyperhidrosis—Pentoxifylline—malaria	0.000203	0.00115	CcSEcCtD
Nilotinib—Vomiting—Sulfadiazine—malaria	0.000202	0.00115	CcSEcCtD
Nilotinib—Decreased appetite—Quinine—malaria	0.000202	0.00115	CcSEcCtD
Nilotinib—Decreased appetite—Quinidine—malaria	0.000202	0.00115	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Quinine—malaria	0.000201	0.00114	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Quinidine—malaria	0.000201	0.00114	CcSEcCtD
Nilotinib—Rash—Sulfadiazine—malaria	0.000201	0.00114	CcSEcCtD
Nilotinib—Dermatitis—Sulfadiazine—malaria	0.000201	0.00114	CcSEcCtD
Nilotinib—Gastrointestinal pain—Dapsone—malaria	0.0002	0.00114	CcSEcCtD
Nilotinib—Anorexia—Quinidine barbiturate—malaria	0.0002	0.00114	CcSEcCtD
Nilotinib—Anorexia—Pentoxifylline—malaria	0.0002	0.00113	CcSEcCtD
Nilotinib—Headache—Sulfadiazine—malaria	0.000199	0.00113	CcSEcCtD
Nilotinib—Hypotension—Quinidine barbiturate—malaria	0.000196	0.00111	CcSEcCtD
Nilotinib—Hypotension—Pentoxifylline—malaria	0.000196	0.00111	CcSEcCtD
Nilotinib—CYP3A4—kidney—malaria	0.000195	0.00142	CbGeAlD
Nilotinib—Gastrointestinal pain—Clindamycin—malaria	0.000194	0.0011	CcSEcCtD
Nilotinib—Abdominal pain—Dapsone—malaria	0.000194	0.0011	CcSEcCtD
Nilotinib—Body temperature increased—Dapsone—malaria	0.000194	0.0011	CcSEcCtD
Nilotinib—Feeling abnormal—Quinidine—malaria	0.000192	0.00109	CcSEcCtD
Nilotinib—Feeling abnormal—Quinine—malaria	0.000192	0.00109	CcSEcCtD
Nilotinib—CYP2D6—kidney—malaria	0.000191	0.00139	CbGeAlD
Nilotinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000191	0.00109	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000191	0.00108	CcSEcCtD
Nilotinib—CA2—liver—malaria	0.000191	0.00139	CbGeAlD
Nilotinib—Gastrointestinal pain—Quinine—malaria	0.00019	0.00108	CcSEcCtD
Nilotinib—Gastrointestinal pain—Quinidine—malaria	0.00019	0.00108	CcSEcCtD
Nilotinib—Insomnia—Pentoxifylline—malaria	0.00019	0.00108	CcSEcCtD
Nilotinib—Nausea—Sulfadiazine—malaria	0.000189	0.00107	CcSEcCtD
Nilotinib—Urticaria—Clindamycin—malaria	0.000188	0.00107	CcSEcCtD
Nilotinib—Abdominal pain—Clindamycin—malaria	0.000187	0.00106	CcSEcCtD
Nilotinib—Body temperature increased—Clindamycin—malaria	0.000187	0.00106	CcSEcCtD
Nilotinib—Dyspnoea—Quinidine barbiturate—malaria	0.000187	0.00106	CcSEcCtD
Nilotinib—Dyspnoea—Pentoxifylline—malaria	0.000187	0.00106	CcSEcCtD
Nilotinib—Urticaria—Quinidine—malaria	0.000185	0.00105	CcSEcCtD
Nilotinib—Urticaria—Quinine—malaria	0.000185	0.00105	CcSEcCtD
Nilotinib—Dyspepsia—Pentoxifylline—malaria	0.000184	0.00105	CcSEcCtD
Nilotinib—Abdominal pain—Quinine—malaria	0.000184	0.00104	CcSEcCtD
Nilotinib—Abdominal pain—Quinidine—malaria	0.000184	0.00104	CcSEcCtD
Nilotinib—Body temperature increased—Quinidine—malaria	0.000184	0.00104	CcSEcCtD
Nilotinib—Body temperature increased—Quinine—malaria	0.000184	0.00104	CcSEcCtD
Nilotinib—Decreased appetite—Quinidine barbiturate—malaria	0.000182	0.00104	CcSEcCtD
Nilotinib—CA4—brain—malaria	0.000182	0.00133	CbGeAlD
Nilotinib—Decreased appetite—Pentoxifylline—malaria	0.000182	0.00103	CcSEcCtD
Nilotinib—CYP2C8—liver—malaria	0.000182	0.00132	CbGeAlD
Nilotinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000181	0.00103	CcSEcCtD
Nilotinib—Pain—Quinidine barbiturate—malaria	0.00018	0.00102	CcSEcCtD
Nilotinib—Constipation—Quinidine barbiturate—malaria	0.00018	0.00102	CcSEcCtD
Nilotinib—Constipation—Pentoxifylline—malaria	0.000179	0.00102	CcSEcCtD
Nilotinib—ABCG2—liver—malaria	0.000177	0.00128	CbGeAlD
Nilotinib—Hypersensitivity—Clindamycin—malaria	0.000175	0.000992	CcSEcCtD
Nilotinib—Feeling abnormal—Quinidine barbiturate—malaria	0.000173	0.000983	CcSEcCtD
Nilotinib—Feeling abnormal—Pentoxifylline—malaria	0.000173	0.000981	CcSEcCtD
Nilotinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000172	0.000975	CcSEcCtD
Nilotinib—Hypersensitivity—Quinidine—malaria	0.000171	0.000974	CcSEcCtD
Nilotinib—Hypersensitivity—Quinine—malaria	0.000171	0.000974	CcSEcCtD
Nilotinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000171	0.000973	CcSEcCtD
Nilotinib—Asthenia—Clindamycin—malaria	0.00017	0.000966	CcSEcCtD
Nilotinib—ABCB1—hematopoietic system—malaria	0.000168	0.00122	CbGeAlD
Nilotinib—Pruritus—Clindamycin—malaria	0.000168	0.000953	CcSEcCtD
Nilotinib—Asthenia—Quinidine—malaria	0.000167	0.000948	CcSEcCtD
Nilotinib—Asthenia—Quinine—malaria	0.000167	0.000948	CcSEcCtD
Nilotinib—Urticaria—Quinidine barbiturate—malaria	0.000167	0.000947	CcSEcCtD
Nilotinib—Urticaria—Pentoxifylline—malaria	0.000166	0.000946	CcSEcCtD
Nilotinib—Body temperature increased—Quinidine barbiturate—malaria	0.000166	0.000943	CcSEcCtD
Nilotinib—Abdominal pain—Quinidine barbiturate—malaria	0.000166	0.000943	CcSEcCtD
Nilotinib—Body temperature increased—Pentoxifylline—malaria	0.000166	0.000941	CcSEcCtD
Nilotinib—Abdominal pain—Pentoxifylline—malaria	0.000166	0.000941	CcSEcCtD
Nilotinib—CYP3A4—digestive system—malaria	0.000165	0.0012	CbGeAlD
Nilotinib—Pruritus—Quinidine—malaria	0.000165	0.000935	CcSEcCtD
Nilotinib—Pruritus—Quinine—malaria	0.000165	0.000935	CcSEcCtD
Nilotinib—CYP2B6—liver—malaria	0.000163	0.00118	CbGeAlD
Nilotinib—CYP2D6—digestive system—malaria	0.000162	0.00118	CbGeAlD
Nilotinib—Diarrhoea—Clindamycin—malaria	0.000162	0.000922	CcSEcCtD
Nilotinib—CYP2C9—liver—malaria	0.000161	0.00117	CbGeAlD
Nilotinib—Diarrhoea—Quinine—malaria	0.000159	0.000904	CcSEcCtD
Nilotinib—Diarrhoea—Quinidine—malaria	0.000159	0.000904	CcSEcCtD
Nilotinib—CYP3A4—blood—malaria	0.000157	0.00114	CbGeAlD
Nilotinib—Dizziness—Clindamycin—malaria	0.000157	0.000891	CcSEcCtD
Nilotinib—Vomiting—Dapsone—malaria	0.000156	0.000885	CcSEcCtD
Nilotinib—CYP2D6—blood—malaria	0.000155	0.00113	CbGeAlD
Nilotinib—Hypersensitivity—Quinidine barbiturate—malaria	0.000155	0.000879	CcSEcCtD
Nilotinib—Hypersensitivity—Pentoxifylline—malaria	0.000154	0.000877	CcSEcCtD
Nilotinib—Dizziness—Quinine—malaria	0.000154	0.000874	CcSEcCtD
Nilotinib—Dizziness—Quinidine—malaria	0.000154	0.000874	CcSEcCtD
Nilotinib—Headache—Dapsone—malaria	0.000154	0.000872	CcSEcCtD
Nilotinib—CA2—brain—malaria	0.000151	0.0011	CbGeAlD
Nilotinib—Vomiting—Clindamycin—malaria	0.000151	0.000856	CcSEcCtD
Nilotinib—Asthenia—Quinidine barbiturate—malaria	0.000151	0.000856	CcSEcCtD
Nilotinib—Asthenia—Pentoxifylline—malaria	0.00015	0.000854	CcSEcCtD
Nilotinib—Rash—Clindamycin—malaria	0.00015	0.000849	CcSEcCtD
Nilotinib—Dermatitis—Clindamycin—malaria	0.000149	0.000849	CcSEcCtD
Nilotinib—Headache—Clindamycin—malaria	0.000149	0.000844	CcSEcCtD
Nilotinib—Pruritus—Quinidine barbiturate—malaria	0.000149	0.000844	CcSEcCtD
Nilotinib—Pruritus—Pentoxifylline—malaria	0.000148	0.000842	CcSEcCtD
Nilotinib—Vomiting—Quinidine—malaria	0.000148	0.00084	CcSEcCtD
Nilotinib—Vomiting—Quinine—malaria	0.000148	0.00084	CcSEcCtD
Nilotinib—Rash—Quinidine—malaria	0.000147	0.000833	CcSEcCtD
Nilotinib—Rash—Quinine—malaria	0.000147	0.000833	CcSEcCtD
Nilotinib—Dermatitis—Quinidine—malaria	0.000147	0.000832	CcSEcCtD
Nilotinib—Dermatitis—Quinine—malaria	0.000147	0.000832	CcSEcCtD
Nilotinib—Headache—Quinine—malaria	0.000146	0.000828	CcSEcCtD
Nilotinib—Headache—Quinidine—malaria	0.000146	0.000828	CcSEcCtD
Nilotinib—Nausea—Dapsone—malaria	0.000146	0.000827	CcSEcCtD
Nilotinib—CYP2C8—brain—malaria	0.000144	0.00105	CbGeAlD
Nilotinib—Diarrhoea—Quinidine barbiturate—malaria	0.000144	0.000816	CcSEcCtD
Nilotinib—Diarrhoea—Pentoxifylline—malaria	0.000143	0.000815	CcSEcCtD
Nilotinib—Nausea—Clindamycin—malaria	0.000141	0.0008	CcSEcCtD
Nilotinib—ABCG2—brain—malaria	0.00014	0.00102	CbGeAlD
Nilotinib—Dizziness—Quinidine barbiturate—malaria	0.000139	0.000789	CcSEcCtD
Nilotinib—Dizziness—Pentoxifylline—malaria	0.000139	0.000787	CcSEcCtD
Nilotinib—Nausea—Quinidine—malaria	0.000138	0.000785	CcSEcCtD
Nilotinib—Nausea—Quinine—malaria	0.000138	0.000785	CcSEcCtD
Nilotinib—ABCB1—kidney—malaria	0.000138	0.001	CbGeAlD
Nilotinib—Vomiting—Quinidine barbiturate—malaria	0.000133	0.000758	CcSEcCtD
Nilotinib—Vomiting—Pentoxifylline—malaria	0.000133	0.000757	CcSEcCtD
Nilotinib—Rash—Quinidine barbiturate—malaria	0.000132	0.000752	CcSEcCtD
Nilotinib—Dermatitis—Quinidine barbiturate—malaria	0.000132	0.000751	CcSEcCtD
Nilotinib—Rash—Pentoxifylline—malaria	0.000132	0.000751	CcSEcCtD
Nilotinib—Dermatitis—Pentoxifylline—malaria	0.000132	0.00075	CcSEcCtD
Nilotinib—Headache—Quinidine barbiturate—malaria	0.000132	0.000747	CcSEcCtD
Nilotinib—Headache—Pentoxifylline—malaria	0.000131	0.000746	CcSEcCtD
Nilotinib—CYP2B6—brain—malaria	0.000129	0.00094	CbGeAlD
Nilotinib—Nausea—Quinidine barbiturate—malaria	0.000125	0.000708	CcSEcCtD
Nilotinib—Nausea—Pentoxifylline—malaria	0.000124	0.000707	CcSEcCtD
Nilotinib—CYP3A4—liver—malaria	0.000123	0.000894	CbGeAlD
Nilotinib—CYP2D6—liver—malaria	0.000121	0.00088	CbGeAlD
Nilotinib—ABCB1—digestive system—malaria	0.000117	0.00085	CbGeAlD
Nilotinib—ABCB1—blood—malaria	0.000111	0.00081	CbGeAlD
Nilotinib—ABCB1—bone marrow—malaria	0.000108	0.000783	CbGeAlD
Nilotinib—CYP2D6—brain—malaria	9.6e-05	0.000698	CbGeAlD
Nilotinib—ABCB1—liver—malaria	8.7e-05	0.000633	CbGeAlD
Nilotinib—ABCB1—brain—malaria	6.91e-05	0.000502	CbGeAlD
Nilotinib—ABCB1—Metabolism—SLC4A1—malaria	1.48e-05	0.000102	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.47e-05	0.000101	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—ICAM1—malaria	1.46e-05	0.0001	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL18—malaria	1.46e-05	0.0001	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD40LG—malaria	1.45e-05	9.99e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HBB—malaria	1.45e-05	9.96e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD8A—malaria	1.44e-05	9.88e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—CRP—malaria	1.43e-05	9.85e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL18—malaria	1.43e-05	9.82e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD40LG—malaria	1.42e-05	9.78e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL18—malaria	1.42e-05	9.78e-05	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—IL2—malaria	1.42e-05	9.75e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD4—malaria	1.42e-05	9.74e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD40LG—malaria	1.41e-05	9.74e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—HPGDS—malaria	1.41e-05	9.72e-05	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—IL2—malaria	1.41e-05	9.7e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD8A—malaria	1.41e-05	9.67e-05	CbGpPWpGaD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.4e-05	9.64e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD8A—malaria	1.4e-05	9.63e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SLC4A1—malaria	1.4e-05	9.62e-05	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TNF—malaria	1.4e-05	9.62e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DECR1—malaria	1.39e-05	9.59e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IFNG—malaria	1.39e-05	9.59e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IFNG—malaria	1.39e-05	9.59e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IFNG—malaria	1.39e-05	9.56e-05	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD4—malaria	1.39e-05	9.54e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SLC4A1—malaria	1.38e-05	9.53e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-B—malaria	1.38e-05	9.51e-05	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD4—malaria	1.38e-05	9.5e-05	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—IL6—malaria	1.38e-05	9.49e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—TLR4—malaria	1.37e-05	9.45e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL1B—malaria	1.37e-05	9.44e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—CD4—malaria	1.37e-05	9.44e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL2—malaria	1.37e-05	9.41e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD4—malaria	1.36e-05	9.36e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—G6PD—malaria	1.36e-05	9.35e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CRP—malaria	1.35e-05	9.33e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD36—malaria	1.35e-05	9.32e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL18—malaria	1.35e-05	9.31e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-B—malaria	1.35e-05	9.31e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD40LG—malaria	1.35e-05	9.28e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD4—malaria	1.35e-05	9.26e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD4—malaria	1.35e-05	9.26e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-B—malaria	1.35e-05	9.26e-05	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—IL2—malaria	1.34e-05	9.24e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—IL6—malaria	1.34e-05	9.24e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD4—malaria	1.34e-05	9.23e-05	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—IL6—malaria	1.34e-05	9.2e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD8A—malaria	1.33e-05	9.17e-05	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD4—malaria	1.33e-05	9.16e-05	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—IL6—malaria	1.33e-05	9.14e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD36—malaria	1.33e-05	9.13e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—NOS2—malaria	1.32e-05	9.11e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD36—malaria	1.32e-05	9.08e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—ICAM1—malaria	1.32e-05	9.06e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD4—malaria	1.31e-05	9.04e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DECR1—malaria	1.31e-05	9.04e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—DHFR—malaria	1.31e-05	9.02e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DECR1—malaria	1.3e-05	8.96e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TLR4—malaria	1.3e-05	8.94e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—SCARB1—malaria	1.3e-05	8.93e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PKLR—malaria	1.29e-05	8.88e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-B—malaria	1.28e-05	8.82e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HBB—malaria	1.26e-05	8.68e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD36—malaria	1.26e-05	8.65e-05	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—IL6—malaria	1.25e-05	8.6e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—IL6—malaria	1.25e-05	8.58e-05	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—IL6—malaria	1.24e-05	8.57e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—ICAM1—malaria	1.24e-05	8.57e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL1B—malaria	1.24e-05	8.56e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL1B—malaria	1.24e-05	8.56e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL1B—malaria	1.24e-05	8.53e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL2—malaria	1.24e-05	8.52e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL2—malaria	1.24e-05	8.52e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—KDR—malaria	1.23e-05	8.5e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL2—malaria	1.23e-05	8.49e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CRP—malaria	1.22e-05	8.4e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—NOS2—malaria	1.2e-05	8.3e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CRP—malaria	1.19e-05	8.23e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CRP—malaria	1.19e-05	8.19e-05	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—IL6—malaria	1.19e-05	8.19e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HBB—malaria	1.19e-05	8.18e-05	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—IL6—malaria	1.18e-05	8.15e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HBB—malaria	1.18e-05	8.11e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—KDR—malaria	1.17e-05	8.08e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TLR4—malaria	1.17e-05	8.06e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL18—malaria	1.17e-05	8.05e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD40LG—malaria	1.16e-05	8.02e-05	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—IL2—malaria	1.16e-05	7.99e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD8A—malaria	1.15e-05	7.93e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—G6PD—malaria	1.15e-05	7.91e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—TLR4—malaria	1.15e-05	7.89e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NOS2—malaria	1.14e-05	7.85e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TLR4—malaria	1.14e-05	7.85e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD4—malaria	1.14e-05	7.82e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.13e-05	7.81e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CRP—malaria	1.13e-05	7.8e-05	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—IL6—malaria	1.13e-05	7.76e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PKLR—malaria	1.12e-05	7.73e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—ICAM1—malaria	1.12e-05	7.72e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IFNG—malaria	1.11e-05	7.64e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-B—malaria	1.11e-05	7.63e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—ICAM1—malaria	1.1e-05	7.56e-05	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	1.1e-05	7.54e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ICAM1—malaria	1.09e-05	7.53e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD4—malaria	1.09e-05	7.51e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD36—malaria	1.09e-05	7.48e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TLR4—malaria	1.09e-05	7.48e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—IL6—malaria	1.08e-05	7.41e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DHODH—malaria	1.07e-05	7.39e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD4—malaria	1.07e-05	7.38e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PKLR—malaria	1.06e-05	7.29e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—malaria	1.05e-05	7.24e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PKLR—malaria	1.05e-05	7.23e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—malaria	1.05e-05	7.21e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ICAM1—malaria	1.04e-05	7.17e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—HPGDS—malaria	1.04e-05	7.13e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NOS2—malaria	1.03e-05	7.07e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—G6PD—malaria	1e-05	6.89e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IFNG—malaria	1e-05	6.89e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—malaria	9.97e-06	6.86e-05	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—IL6—malaria	9.95e-06	6.85e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL1B—malaria	9.9e-06	6.82e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL2—malaria	9.86e-06	6.79e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—KDR—malaria	9.84e-06	6.77e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD4—malaria	9.8e-06	6.75e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CRP—malaria	9.79e-06	6.74e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—KDR—malaria	9.74e-06	6.71e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD4—malaria	9.67e-06	6.66e-05	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.65e-06	6.65e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—DHFR—malaria	9.6e-06	6.61e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CD36—malaria	9.59e-06	6.6e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—SCARB1—malaria	9.5e-06	6.54e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IFNG—malaria	9.47e-06	6.52e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—G6PD—malaria	9.43e-06	6.5e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—TLR4—malaria	9.39e-06	6.46e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—G6PD—malaria	9.35e-06	6.44e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	9.23e-06	6.35e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD4—malaria	9.15e-06	6.3e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC4A1—malaria	9.13e-06	6.29e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—ICAM1—malaria	9e-06	6.2e-05	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—IL6—malaria	8.97e-06	6.18e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL1B—malaria	8.93e-06	6.15e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—CD4—malaria	8.92e-06	6.14e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL2—malaria	8.89e-06	6.12e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—KDR—malaria	8.87e-06	6.11e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HPGDS—malaria	8.76e-06	6.03e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DECR1—malaria	8.59e-06	5.91e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IFNG—malaria	8.53e-06	5.88e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—IL6—malaria	8.5e-06	5.85e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—IL6—malaria	8.48e-06	5.84e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL1B—malaria	8.45e-06	5.82e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD4—malaria	8.45e-06	5.82e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—IL6—malaria	8.45e-06	5.81e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL2—malaria	8.42e-06	5.8e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—KDR—malaria	8.4e-06	5.78e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IFNG—malaria	8.36e-06	5.75e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IFNG—malaria	8.32e-06	5.73e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS2—malaria	8.24e-06	5.68e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD4—malaria	8.24e-06	5.68e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CD36—malaria	8.14e-06	5.6e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—DHFR—malaria	8.13e-06	5.6e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD4—malaria	8.07e-06	5.56e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SCARB1—malaria	8.05e-06	5.54e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—IL6—malaria	8.04e-06	5.54e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD4—malaria	8.03e-06	5.53e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL6—malaria	8.03e-06	5.53e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL2—malaria	8e-06	5.51e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IFNG—malaria	7.92e-06	5.45e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HBB—malaria	7.76e-06	5.35e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—IL6—malaria	7.65e-06	5.27e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD4—malaria	7.65e-06	5.27e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HPGDS—malaria	7.63e-06	5.26e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1B—malaria	7.61e-06	5.24e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD4—malaria	7.61e-06	5.24e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL2—malaria	7.61e-06	5.24e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL2—malaria	7.58e-06	5.22e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—KDR—malaria	7.56e-06	5.21e-05	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—IL6—malaria	7.49e-06	5.16e-05	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—IL6—malaria	7.46e-06	5.14e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1B—malaria	7.45e-06	5.13e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL2—malaria	7.43e-06	5.11e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1B—malaria	7.42e-06	5.11e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—IL6—malaria	7.41e-06	5.1e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—KDR—malaria	7.41e-06	5.1e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL2—malaria	7.39e-06	5.09e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL6—malaria	7.28e-06	5.01e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL6—malaria	7.28e-06	5.01e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL6—malaria	7.25e-06	4.99e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HPGDS—malaria	7.19e-06	4.95e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HPGDS—malaria	7.13e-06	4.91e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—IL6—malaria	7.1e-06	4.89e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DHFR—malaria	7.08e-06	4.88e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—malaria	7.07e-06	4.87e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL2—malaria	7.04e-06	4.85e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—KDR—malaria	7.02e-06	4.83e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SCARB1—malaria	7.01e-06	4.83e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PKLR—malaria	6.92e-06	4.76e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFNG—malaria	6.85e-06	4.72e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DHFR—malaria	6.67e-06	4.6e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DHFR—malaria	6.62e-06	4.56e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—malaria	6.61e-06	4.55e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SCARB1—malaria	6.61e-06	4.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SCARB1—malaria	6.55e-06	4.51e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL2—malaria	6.38e-06	4.39e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL2—malaria	6.32e-06	4.35e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—G6PD—malaria	6.17e-06	4.25e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—malaria	6.14e-06	4.23e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—malaria	6.11e-06	4.21e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—malaria	6.11e-06	4.21e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL2—malaria	6.09e-06	4.19e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—KDR—malaria	6.07e-06	4.18e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CD36—malaria	5.96e-06	4.11e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—malaria	5.8e-06	3.99e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL2—malaria	5.75e-06	3.96e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL2—malaria	5.44e-06	3.75e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—malaria	5.3e-06	3.65e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—malaria	5.23e-06	3.6e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CD36—malaria	5.05e-06	3.48e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—malaria	4.95e-06	3.41e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL2—malaria	4.9e-06	3.38e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—malaria	4.83e-06	3.32e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL2—malaria	4.8e-06	3.31e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—malaria	4.7e-06	3.24e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HPGDS—malaria	4.7e-06	3.24e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—malaria	4.57e-06	3.15e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL2—malaria	4.55e-06	3.13e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—malaria	4.47e-06	3.08e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—malaria	4.46e-06	3.07e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD36—malaria	4.4e-06	3.03e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—malaria	4.36e-06	3.01e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DHFR—malaria	4.36e-06	3e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—malaria	4.34e-06	2.99e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SCARB1—malaria	4.32e-06	2.97e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD36—malaria	4.15e-06	2.85e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—malaria	4.14e-06	2.85e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—malaria	4.12e-06	2.83e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD36—malaria	4.11e-06	2.83e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL2—malaria	3.93e-06	2.71e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—malaria	3.75e-06	2.58e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—malaria	3.71e-06	2.56e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—malaria	3.58e-06	2.46e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—malaria	3.38e-06	2.33e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—malaria	3.3e-06	2.27e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—malaria	3.2e-06	2.2e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—malaria	2.88e-06	1.98e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—malaria	2.82e-06	1.94e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD36—malaria	2.71e-06	1.87e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—malaria	2.67e-06	1.84e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—malaria	2.31e-06	1.59e-05	CbGpPWpGaD
